Advancing Parkinson's disease biopathology and drug discovery by dual cellular modelling
Parkinson's disease (PD) is the fastest growing neurological disorder in the world. Its pathologic hallmarks are dopaminergic neuronal loss in the substantia nigra and alpha-synuclein accumulation in neurons. However, the patho-biologic mechanisms are largely unknown. Current drugs cannot slow...
Published in: | Journal of King Saud University - Science |
---|---|
Main Author: | Chua P.; Ulfa Seruji N.M.; Lizazman M.A.; Mian Jong V.Y.; Lim W.K. |
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211030729&doi=10.1016%2fj.jksus.2024.103559&partnerID=40&md5=32d43d5123fbeec5c2a3a0bbcec747cd |
Similar Items
-
Advancing Parkinson's disease biopathology and drug discovery by dual cellular modelling
by: Chua, et al.
Published: (2024) -
A review of bisindolylmethane as an important scaffold for drug discovery
by: Imran S.; Taha M.; Ismail N.H.
Published: (2015) -
Biotransformation of steroids: Accelerating discovery of new drugs in the pharmaceutical industry
by: Sultan S.; Singh G.K.S.; Ashraf K.; Ashraf M.
Published: (2023) -
Drug nanocarrier, the future of atopic diseases: Advanced drug delivery systems and smart management of disease
by: Shao M.; Hussain Z.; Thu H.E.; Khan S.; Katas H.; Ahmed T.A.; Tripathy M.; Leng J.; Qin H.-L.; Bukhari S.N.A.
Published: (2016) -
Computational approaches: Discovery of GTPase HRas as prospective drug target for 1,3-diazine scaffolds
by: Kumar S.; Sharma D.; Narasimhan B.; Ramasamy K.; Shah S.A.A.; Lim S.M.; Mani V.
Published: (2019)